Pharmacy

AMH & APF

Yusri Kardo

01 Jan 2022 • 3 min read

For the two important resources, the way I went about flagging or labelling the AMH is by creating a contents page that I stuck onto the textbooks that I could easily refer to before navigating to the area that I needed. This method was used for the written exam only and not the oral exam.

Below are the contents pages that I created, as well as specific pages that flagged in each text books:

APF contents page:

- Compounding and dispensing:

Table A1: recommended CAL labels for medicines- page 17
Table A2: CAL 21 medicines – special handling & disposal required- page 25
Table A5: examples of medicines that should not be crushed & possible alternative treatment options- page 67
Table A7: SCE values page 78

- Principles of drug therapy:

Table B3. Average wt, ht and body surface areas for children from birth to 14 years- page 99
Table B6. Examples of cytochrome P450 substrates, inhibitors and inducers- page 109
Table B7. Potentially serious drug interactions: some examples- page 111
Reduced effectiveness of oral contraceptive- page 112
Serotonin toxicity- page 113
Elderly- medicines that pose a high risk of anticholinergic effects- page 124
Table B9. Pharmacokinetic data- page 129
TDM- Table B10. Drugs commonly monitored in clinical practice- page 143

- Therapeutic management

Table C1. Systemic corticosteroids: relative potencies and equivalent doses- page 150
Table C3. Topical corticosteroids: potency of commonly used dermatological preps- page 152
Table C5. Activity characteristics of insulins- page 157
Table C6. Medicines that cause discoloration of urine- page 159
Table C7. Medicines that can cause discoloration of faeces- page 159
Table C9. Examples of medicines that can cause or exacerbate urinary incontinence- page 162
Figure C4. Managing missed COC doses- page 166
Normal physiological values contents- page 168
Opioid conversion- page 192

- Complementary medicines monographs

Table E1. CAMs that have been used for specific health conditions- page 461

- Health information and resources

Table I3. Recommended minimum exclusion periods for infectious conditions: schools, preschools and childcare centres- page 623

APF pages flagged:

Flagged the letters of the index

AMH contents page:

- Compounding and dispensing:

Table A1: recommended CAL labels for medicines- page 17
Table A2: CAL 21 medicines – special handling & disposal required- page 25
Table A5: examples of medicines that should not be crushed & possible alternative treatment options- page 67
Table A7: SCE values page 78

- Principles of drug therapy:

Table B3. Average wt, ht and body surface areas for children from birth to 14 years- page 99
Table B6. Examples of cytochrome P450 substrates, inhibitors and inducers- page 109
Table B7. Potentially serious drug interactions: some examples- page 111
Reduced effectiveness of oral contraceptive- page 112
Serotonin toxicity- page 113
Elderly- medicines that pose a high risk of anticholinergic effects- page 124
Table B9. Pharmacokinetic data- page 129
TDM- Table B10. Drugs commonly monitored in clinical practice- page 143

- Therapeutic management

Table C1. Systemic corticosteroids: relative potencies and equivalent doses- page 150
Table C3. Topical corticosteroids: potency of commonly used dermatological preps- page 152
Table C5. Activity characteristics of insulins- page 157
Table C6. Medicines that cause discoloration of urine- page 159
Table C7. Medicines that can cause discoloration of faeces- page 159
Table C9. Examples of medicines that can cause or exacerbate urinary incontinence- page 162
Figure C4. Managing missed COC doses- page 166
Normal physiological values contents- page 168
Opioid conversion- page 192

- Complementary medicines monographs

Table E1. CAMs that have been used for specific health conditions- page 461

- Health information and resources

Table I3. Recommended minimum exclusion periods for infectious conditions: schools, preschools and childcare centres- page 623

AMH pages flagged:

Flagged the letters of the index
Appendix D: reference ranges for common laboratory values on page 1111
Drug interactions page 940
Table D1-1: drugs that may increase the risk of seizures on page 1093
Table D1-2: drugs with anticholinergic effects on page 1093
Table D1-3: drugs and glycoproteins on page l093
Table D1-4: drugs and cyp enzymes on page 1094

These contents pages were used in 2021 & refer to the AMH/APF in this year so this document may not be up to date with the current textbooks and may need to be updated prior to being used.

**Disclaimer: This is my personal experience and in no way shape or form am I liable for your performance in the pharmacy exams you undertake. This information is only provided to give an insight into my personal experience which may benefit you in your intern year and should not form the complete basis for your study.